The foundation is comprised of pumpkin growers who in 2013 committed to donating funds for every pink pumpkin sold to a breast cancer research organization. Future Farmers of America students also raise money for the foundation through sales of the pumpkins.
The grant will fund Rush University research identifying cancer mechanisms and a proposal for a clinical trial evaluating adjuvant aspirin therapy in PIK3CA-mutant breast cancers, according to a news release.
“We are thrilled to be able to make a contribution to cancer research and hope this puts us one step closer to finding a cure,” Carol Holsopple-Froese, foundation president and a breast cancer survivor, said in the release.
A Rush University Medical Center laboratory focuses on translational breast cancer genetics. Its research uses genetic techniques to identify molecular mechanisms of drug resistance and identify new targets for existing therapies.